BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8834447)

  • 1. Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilage.
    Olszewski JM; Moore VL; McDonnell J; Williams H; Saphos CA; Green BG; Knight WB; Chapman KT; Hagmann WK; Dorn CP; Hale JJ; Mumford RA
    Connect Tissue Res; 1996; 33(4):291-9. PubMed ID: 8834447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation.
    Bayne EK; MacNaul KL; Donatelli SA; Christen A; Griffin PR; Hoerrner LA; Calaycay JR; Ayala JM; Chapman K; Hagmann W
    Arthritis Rheum; 1995 Oct; 38(10):1400-9. PubMed ID: 7575690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the proteoglycanolytic activities of human leukocyte elastase and human cathepsin G in vitro and in vivo.
    McDonnell J; Lobner JM; Knight WB; Lark MW; Green B; Poe M; Moore VL
    Connect Tissue Res; 1993; 30(1):1-9. PubMed ID: 8149741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.
    Lundberg C; Asberg I; Ionescu M; Reiner A; Smedegård G; Poole AR
    Ann Rheum Dis; 1996 Aug; 55(8):525-34. PubMed ID: 8774180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR
    Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human interleukin-1 beta-induced increase in levels of proteoglycans, stromelysin, and leukocytes in rabbit synovial fluid.
    McDonnell J; Hoerrner LA; Lark MW; Harper C; Dey T; Lobner J; Eiermann G; Kazazis D; Singer II; Moore VL
    Arthritis Rheum; 1992 Jul; 35(7):799-805. PubMed ID: 1320383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cartilage metabolism in the injured and uninjured knee of the same patient.
    Dahlberg L; Roos H; Saxne T; Heinegård D; Lark MW; Hoerrner LA; Lohmander LS
    Ann Rheum Dis; 1994 Dec; 53(12):823-7. PubMed ID: 7864691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
    Sandy JD; Verscharen C
    Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints.
    Skiöldebrand E; Lorenzo P; Zunino L; Rucklidge GJ; Sandgren B; Carlsten J; Ekman S
    Equine Vet J; 2001 Jul; 33(4):394-402. PubMed ID: 11469774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the phospholipase A2 inhibitor, manoalide, on cartilage degradation, stromelysin expression, and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1 alpha in the rabbit.
    Schrier DJ; Flory CM; Finkel M; Kuchera SL; Lesch ME; Jacobson PB
    Arthritis Rheum; 1996 Aug; 39(8):1292-9. PubMed ID: 8702436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of stromelysin on the composition and physical properties of rabbit articular cartilage in the presence and absence of a synthetic inhibitor.
    Bonassar LJ; Jeffries KA; Frank EH; Moore VL; Lark MW; Bayne EK; McDonnell J; Olszewski J; Hagmann W; Chapman K
    Arthritis Rheum; 1995 Nov; 38(11):1678-86. PubMed ID: 7488290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan-binding region of aggrecan from pig laryngeal cartilage. Amino acid sequence, analysis of N-linked oligosaccharides and location of the keratan sulphate.
    Barry FP; Gaw JU; Young CN; Neame PJ
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):761-9. PubMed ID: 1417734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of hyaluronan export prevent proteoglycan loss from osteoarthritic cartilage.
    Prehm P
    J Rheumatol; 2005 Apr; 32(4):690-6. PubMed ID: 15801027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N- and O-linked keratan sulfate on the hyaluronan binding region of aggrecan from mature and immature bovine cartilage.
    Barry FP; Rosenberg LC; Gaw JU; Gaw JU; Koob TJ; Neame PJ
    J Biol Chem; 1995 Sep; 270(35):20516-24. PubMed ID: 7657627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity.
    van Meurs J; van Lent P; Stoop R; Holthuysen A; Singer I; Bayne E; Mudgett J; Poole R; Billinghurst C; van der Kraan P; Buma P; van den Berg W
    Arthritis Rheum; 1999 Oct; 42(10):2074-84. PubMed ID: 10524678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
    Stanton H; Ung L; Fosang AJ
    Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella.
    Väätäinen U; Lohmander LS; Thonar E; Hongisto T; Agren U; Rönkkö S; Jaroma H; Kosma VM; Tammi M; Kiviranta I
    Osteoarthritis Cartilage; 1998 Mar; 6(2):115-24. PubMed ID: 9692066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.